25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance
- PMID: 16868705
- DOI: 10.1007/s11255-006-0081-7
25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance
Abstract
In terms of both exogenous sources (diet), and endogenous production (activation through exposure to ultraviolet light), vitamin D is unique. Few foods naturally contain vitamin D and only a few are fortified with vitamin D. Most people get more than 90% of their vitamin D requirements from exposure to sunlight. Those who protect their skin from ultraviolet-B radiation with clothing or sunscreen, the elderly, and dark-skinned individuals have limited capacity to produce vitamin D. Vitamin D deficiency is common in the general population and even more common in patients with chronic renal failure (CKD). Increased use of sun-blocking agents and decreased exposure to sunlight, to reduce the risk of skin cancer, attributed to exposure to UV radiation, may contribute to the increase in vitamin D deficiency in the population. These issues are particularly important in the dialysis population who are at particular risk because these, mostly elderly, individuals have an inactive life style and have reduced exposure to sunshine and UV light, thus limiting the actinic synthesis of vitamin D. The nephrology community seems to have overlooked the importance of vitamin D for overall health and well being in patients with CKD. Recently however, several authors have called attention to the role of plasma 25(OH)D3 levels in mineral metabolism dysregulation in patients with chronic kidney diseases, and those on dialysis. Vitamin D not only contributes to skeletal health but also plays a major role in the health of a wide variety of other organ systems. It seems that vitamin D supplementation is the most effective way of preventing vitamin D deficiency.
Similar articles
-
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.Hemodial Int. 2007 Jul;11(3):315-21. doi: 10.1111/j.1542-4758.2007.00186.x. Hemodial Int. 2007. PMID: 17576296 Clinical Trial.
-
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].Nefrologia. 2008;28 Suppl 3:67-78. Nefrologia. 2008. PMID: 19018742 Spanish.
-
[Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].Nefrologia. 2008;28 Suppl 5:39-45. Nefrologia. 2008. PMID: 18847419 Review. Spanish.
-
Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation.Anticancer Res. 2016 Mar;36(3):1397-401. Anticancer Res. 2016. PMID: 26977042
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Significant independent predictors of vitamin d deficiency in inpatients and outpatients of a nephrology unit.Int J Endocrinol. 2013;2013:237869. doi: 10.1155/2013/237869. Epub 2013 May 12. Int J Endocrinol. 2013. PMID: 23737771 Free PMC article.
-
Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease.Int Urol Nephrol. 2010 Sep;42(3):835-9. doi: 10.1007/s11255-010-9743-6. Epub 2010 May 7. Int Urol Nephrol. 2010. PMID: 20449656
-
The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients' with low vitamin D.Cent Eur J Immunol. 2014;39(2):236-42. doi: 10.5114/ceji.2014.43729. Epub 2014 Jun 27. Cent Eur J Immunol. 2014. PMID: 26155130 Free PMC article.
-
Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations.Int Urol Nephrol. 2009 Dec;41(4):983-8. doi: 10.1007/s11255-008-9509-6. Epub 2008 Dec 5. Int Urol Nephrol. 2009. PMID: 19058025
-
Serum fibroblast growth factor-23 levels in chronic haemodialysis patients.Int Urol Nephrol. 2009;41(1):163-9. doi: 10.1007/s11255-008-9466-0. Epub 2008 Oct 7. Int Urol Nephrol. 2009. PMID: 18839328
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical